| Year |
Citation |
Score |
| 2023 |
Vianzon VV, Hanson RM, Garg I, Joseph GJ, Rogers LM. Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer. Frontiers in Immunology. 14: 1235131. PMID 38143765 DOI: 10.3389/fimmu.2023.1235131 |
0.335 |
|
| 2020 |
Rogers LM, Wang Z, Mott SL, Dupuy AJ, Weiner GJ. A genetic screen to identify gain- and loss-of-function modifications that enhance T-cell infiltration into tumors. Cancer Immunology Research. PMID 32611665 DOI: 10.1158/2326-6066.Cir-20-0056 |
0.66 |
|
| 2020 |
Rogers LM, Dupuy AJ, Weiner GJ. Abstract A51: Rationally improving T cell-mediated cancer immunotherapies using Sleeping Beauty mutagenesis to identify novel therapeutic targets Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A51 |
0.664 |
|
| 2016 |
Sun Z, Yu W, Navarro MS, Sweat M, Eliason S, Sharp T, Liu H, Seidel K, Zhang L, Moreno M, Lynch T, Holton NE, Rogers L, Neff T, Goodheart MJ, et al. Sox2 and Lef-1 interact with Pitx2 to regulate incisor development and stem cell renewal. Development (Cambridge, England). PMID 27660324 DOI: 10.1242/Dev.138883 |
0.577 |
|
| 2016 |
Rogers LM, Dupuy AJ, Weiner GJ. Abstract 526: Identification of novel cancer immunotherapy targets using Sleeping Beauty mutagenesis Immunology. 76: 526-526. DOI: 10.1158/1538-7445.Am2016-526 |
0.655 |
|
| 2014 |
Riordan JD, Drury LJ, Smith RP, Brett BT, Rogers LM, Scheetz TE, Dupuy AJ. Sequencing methods and datasets to improve functional interpretation of sleeping beauty mutagenesis screens. Bmc Genomics. 15: 1150. PMID 25526783 DOI: 10.1186/1471-2164-15-1150 |
0.718 |
|
| 2014 |
Gibson-Corley KN, Rogers LM, Goeken A, Dupuy AJ, Meyerholz DK. Keratoacanthoma Pathobiology in Mouse Models. Diseases (Basel, Switzerland). 2: 106-119. PMID 25309748 DOI: 10.3390/Diseases2020106 |
0.633 |
|
| 2014 |
Rogers LM, Veeramani S, Weiner GJ. Complement in monoclonal antibody therapy of cancer. Immunologic Research. 59: 203-10. PMID 24906530 DOI: 10.1007/S12026-014-8542-Z |
0.379 |
|
| 2013 |
Rogers LM, Olivier AK, Meyerholz DK, Dupuy AJ. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer. Journal of Immunology (Baltimore, Md. : 1950). 190: 4393-9. PMID 23475219 DOI: 10.4049/Jimmunol.1203227 |
0.67 |
|
| 2013 |
Rogers LM, Riordan JD, Swick BL, Meyerholz DK, Dupuy AJ. Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer. The Journal of Investigative Dermatology. 133: 1863-9. PMID 23426136 DOI: 10.1038/Jid.2013.77 |
0.715 |
|
| 2011 |
Nadkarni N, Rogers L, Samuelson M, Neff T, Bender D, Ahmed A, De Geest K, Button A, Dupuy A, Goodheart M. Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations Gynecologic Oncology. 123: 446-447. DOI: 10.1016/J.Ygyno.2011.07.084 |
0.658 |
|
| 2011 |
Riordan JD, Rogers LM, Berquam-Vrieze KE, Dupuy AJ. Sleeping beauty models of cancer Insertional Mutagenesis Strategies in Cancer Genetics. 113-130. DOI: 10.1007/978-1-4419-7656-7_5 |
0.706 |
|
| 2010 |
Rogers LM, Swick BL, Meyerholz DK, Dupuy AJ. Abstract 249: A Sleeping Beauty screen in mice identifies Zmiz1 as a candidate cancer gene in human squamous cell carcinomas Cellular and Molecular Biology. 70: 249-249. DOI: 10.1158/1538-7445.Am10-249 |
0.679 |
|
| 2009 |
Dupuy AJ, Rogers LM, Kim J, Nannapaneni K, Starr TK, Liu P, Largaespada DA, Scheetz TE, Jenkins NA, Copeland NG. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Research. 69: 8150-6. PMID 19808965 DOI: 10.1158/0008-5472.Can-09-1135 |
0.713 |
|
| 2005 |
Downs LS, Rogers LM, Yokoyama Y, Ramakrishnan S. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer. Gynecologic Oncology. 98: 203-10. PMID 15975645 DOI: 10.1016/j.ygyno.2005.04.023 |
0.336 |
|
| Show low-probability matches. |